Studying the use of patients' reprogrammed T-cells to attack cancer as an alternative to more chemo.
Originally published by Meg Wingerter, The Denver Post, on March 14, 2024 Credit: Unsplash/CC0 Public Domain A process of taking patients' own cells and reprogramming them to fight cancer has been a last-ditch option for blood cancer patients when nothing else worked, but a new study underway in Aurora is trying to determine whether more patients could benefit from trying the procedure sooner. Chimeric antigen receptor T cell therapy , known as CAR-T , is a type of immunotherapy that involves taking cells from the patient's body and altering them to attack cancerous cells that have specific proteins on their surfaces. The patient then gets the altered cell